Physician Spotlight – April 2021
Mid-Atlantic Skin operates under the direction of George K. Verghese, MD, one of the nation’s premier dermatologists. Along with his dedicated and professional team, Dr. Verghese provides excellent, comprehensive skin care. Dr. Verghese is a fellow of the American College of Mohs Surgery and the American Academy of Dermatology. He is board certified in dermatology. […]
Battling Skin Cancer? Look No Further than the Non-Surgical SRT-100™ for Your Squamous Cell Carcinoma Treatment
Squamous cell carcinoma is the second most common type of skin cancer. There are more than 700,000 new cases diagnosed each year in the United States. Fortunately, there is a new Squamous Cell Carcinoma Treatment available through Sensus Healthcare – The SRT-100™. What is Squamous Cell Carcinoma? Squamous cell carcinoma develops in the thin, flat […]
SRT-100™: Cure Your Patients with This Revolutionary Non-Surgical Squamous Cell Carcinoma Treatment
Each year, there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and colon. Nearly four million people in the United States will be diagnosed with basal cell or squamous cell carcinoma this year, with an estimated 700,000 of those cases diagnosed as squamous cell carcinoma. Squamous […]
Physician Spotlight – January 2019
Dr. Steven K. Grekin, D.O. is the founder and Medical Director of The Grekin Skin Institute, a dermatological practice providing care within many segments of the medical market in Michigan. His primary mission is to help his patients put their best face forward by delivering extraordinary care and medical treatment. Having completed his undergraduate studies […]
Practical Dermatology – Solving the Keloid Conundrum
Achieving complete keloid scar removal is extremely difficult. The SRT-100 is the only FDA cleared treatment after keloid removal option on the market. Recently the machine was featured in an article on Practical Dermatology’s website. Read the full article here. Read more blogs and news here.
Educating Your Patients on Keloid Removal Success Rates
A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described as an overgrowth of tissue that extends beyond the borders of the original wound, keloids differ from that of hypertrophic […]
NBNA – SRT-100, Game Changer for Keloid Treatment
Dr. Michael H. Gold, a previously featured physician in our Physician Spotlight, has been featured in the Fall 2017 issue of National Black Nurses Association News. Read the article here. SRT-100, Game Changer for Keloid Treatment Treating keloids is very frustrating, not only for the patient suffering from them, but also for the health care […]
When to Suggest SRT Therapy Over Mohs Surgery
For decades, Mohs surgery has been considered the “gold standard” for the treatment of basal cell carcinomas and squamous cell carcinomas, even for cases where cosmetically important features of the face like the eyes, nose, lips, ears, and scalp are the area being treated. As the incidence of basal cell carcinoma and squamous cell carcinoma […]
Should I Get the SRT-100 for My Practice?
Superficial radiation therapy was first used to treat non-melanoma skin cancers, such as basal cell and squamous cell carcinomas, back in the 1970s. For the last few decades, the treatment method fell out of use due to a decline in available machinery. Now, the treatment is making a resurgence as our machine becomes more widespread. […]
What is Superficial Radio Therapy? (SRT)
What is Superficial Radio Therapy? Superficial Radio Therapy is the latest non-invasive, non-melanoma skin cancer treatment option. Superficial Radio Therapy is administered with the use of the SRT-100™, our state-of-the-art system inspired by the tried-and-true Superficial Radio Therapy systems that were once the proven gold standard among dermatologists and radiation oncologists. The difference? Our machine […]
